News

Pricegen reported total revenue of US$1.76 million in Q2 2023 alongside recent developments in its lead therapy PRGN-2012. PGEN had a mean recommendation rating of 2 and a consensus mean price target of US$9.50 as on August 16, 2023.

Brokers upgraded their price targets on USFD following the release of the company’s financial results for Q2 2023. The company reported an increase of 2.1% in net sales to US$9.013 billion in Q2 2022.

Mirati Therapeutics reported total revenue of US$13.69 million for Q2 2023, which resulted in the stock receiving a rating upgrade from brokers. MRTX had a mean recommendation rating of 2.2 and a consensus mean price target of US$54.18 as on August 8 '23

J.P. Morgan upgraded Amazon.com to ‘overweight’ rating as the stock’s earnings results for Q2 2023 beat estimates. AMZN had a mean recommendation rating of 1.7 and a consensus mean price target of US$165.36 as on August 4, 2023.

Corsair received a rating upgrade form Wedblush as the broker believes that it is well positioned as compared to its peers to return to profitability in near-term. Corsair has a mean recommendation rating of 2.3 and a mean consensus price target of US$1

First Solar and Coursera received rating upgrades form analysts following the release of their financial results for the June 2023 quarter. First Solar has a mean recommendation rating of 2 and Coursera has a mean recommendation rating of 2.1 on a scale o

Morgan Stanley upgraded WW International to ‘outperform’ rating, leading to a price surge of 7.35% to US$10.66 premarket. WW had a mean recommendation rating of 2.7. The stock has surpassed its mean recommendation rating of US$9.7.